Expression of TIP-1 Confers Radioresistance of Malignant Glioma Cells

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Han, Miaojun ^a,c,d   Wang, Hailun ^a   Zhang, Hua Tang ^c   Han, Zhaozhong ^a,b,e  

^a VANDERBILT UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c KUNMING INSTITUTE OF ZOOLOGY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^e VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; CDK5 REGULATORY SUBUNIT ASSOCIATED PROTEIN 3; CYTOPLASM PROTEIN; PROTEIN P53; PROTEIN SERINE THREONINE KINASE; PROTEIN TIP 1; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CARBOXY TERMINAL SEQUENCE; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; GENE SILENCING; GLIOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IONIZING RADIATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RADIOSENSITIVITY; TREATMENT RESPONSE; TUMOR XENOGRAFT; TWO HYBRID SYSTEM; UBIQUITINATION; UPREGULATION;

ADP-RIBOSYLATION FACTORS; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; DNA DAMAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOMA; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, NUDE; NERVE TISSUE PROTEINS; RADIATION, IONIZING; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53; TWO-HYBRID SYSTEM TECHNIQUES; UBIQUITINATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84866446060     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045402     Document Type: Article

References (40)

1. Norden AD, Drappatz J, Wen PY, (2009) Antiangiogenic therapies for high-grade glioma. Nat Rev Neurol 5: 610-620.
2. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, et al. (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
3. Momand J, Zambetti GP, Olson DC, George D, Levine AJ, (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69: 1237-1245.
4. Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, et al. (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362: 857-860.
5. Haupt Y, Maya R, Kazaz A, Oren M, (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299.
6. Weber JD, Taylor LJ, Roussel MF, Sherr CJ, Bar-Sagi D, (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nat Cell Biol 1: 20-26.
7. Cheok CF, Verma CS, Baselga J, Lane DP, (2011) Translating p53 into the clinic. Nat Rev Clin Oncol 8: 25-37.
8. Pfeifer GP, Besaratinia A, (2009) Mutational spectra of human cancer. Hum Genet 125: 493-506.
9. Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, et al. (1996) Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2: 985-991.
10. Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, et al. (2002) Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med 346: 420-427.
11. Russo A, Bazan V, Iacopetta B, Kerr D, Soussi T, et al. (2005) The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. J Clin Oncol 23: 7518-7528.
12. Wang J, He X, Luo Y, Yarbrough WG, (2006) A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2. Biochem J 393: 489-501.
13. Jiang H, Luo S, Li H, (2005) Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint. J Biol Chem 280: 20651-20659.
14. Mak GW, Chan MM, Leong VY, Lee JM, Yau TO, et al. (2011) Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis. Cancer Res 71: 2949-2958.
15. Rousset R, Fabre S, Desbois C, Bantignies F, Jalinot P, (1998) The C-terminus of the HTLV-1 Tax oncoprotein mediates interaction with the PDZ domain of cellular proteins. Oncogene 16: 643-654.
16. Alewine C, Olsen O, Wade JB, Welling PA, (2006) TIP-1 Has PDZ Scaffold Antagonist Activity. Mol Biol Cell 17: 4200-4211.
17. Kanamori M, Sandy P, Marzinotto S, Benetti R, Kai C, et al. (2003) The PDZ protein tax-interacting protein-1 inhibits beta-catenin transcriptional activity and growth of colorectal cancer cells. J Biol Chem 278: 38758-38764.
18. Besser J, Leito JT, van der Meer DL, Bagowski CP, (2007) Tip-1 induces filopodia growth and is important for gastrulation movements during zebrafish development. Dev Growth Differ 49: 205-214.
19. Hampson L, Li C, Oliver AW, Kitchener HC, Hampson IN, (2004) The PDZ protein Tip-1 is a gain of function target of the HPV16 E6 oncoprotein. Int J Oncol 25: 1249-1256.
20. Reynaud C, Fabre S, Jalinot P, (2000) The PDZ protein TIP-1 interacts with the Rho effector rhotekin and is involved in Rho signaling to the serum response element. J Biol Chem 275: 33962-33968.
21. Zencir S, Ovee M, Dobson MJ, Banerjee M, Topcu Z, et al. (2011) Identification of brain-specific angiogenesis inhibitor 2 as an interaction partner of glutaminase interacting protein. Biochem Biophys Res Commun 411: 792-797.
22. Oliver AW, He X, Borthwick K, Donne AJ, Hampson L, et al. (2011) The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br J Cancer 104: 324-331.
23. van Ham M, Hendriks W, (2003) PDZ domains-glue and guide. Mol Biol Rep 30: 69-82.
24. Beuming T, Skrabanek L, Niv MY, Mukherjee P, Weinstein H, (2005) PDZBase: a protein-protein interaction database for PDZ-domains. Bioinformatics 21: 827-828.
25. Wang H, Yan H, Fu A, Han M, Hallahan D, et al. (2010) TIP-1 translocation onto the cell plasma membrane is a molecular biomarker of tumor response to ionizing radiation. PLoS One 5: e12051.
26. Han M, Wang H, Zhang HT, Han Z, (2012) The PDZ protein TIP-1 facilitates cell migration and pulmonary metastasis of human invasive breast cancer cells in athymic mice. Biochem Biophys Res Commun 422: 139-145.
27. Felgner PL, Gadek TR, Holm M, Roman R, Chan HW, et al. (1987) Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A 84: 7413-7417.
28. Feng Z, Kachnic L, Zhang J, Powell SN, Xia F, (2004) DNA damage induces p53-dependent BRCA1 nuclear export. J Biol Chem 279: 28574-28584.
29. Rothkamm K, Burdak-Rothkamm S, (2011) Ionizing radiation-induced DNA strand breaks and gamma-H2AXgamma-H2AX foci in cells exposed to nitric oxide. Methods Mol Biol 704: 17-25.
30. Furukawa M, Zhang Y, McCarville J, Ohta T, Xiong Y, (2000) The CUL1 C-terminal sequence and ROC1 are required for efficient nuclear accumulation, NEDD8 modification, and ubiquitin ligase activity of CUL1. Mol Cell Biol 20: 8185-8197.
31. Han Z, Fu A, Wang H, Diaz R, Geng L, et al. (2008) Noninvasive assessment of cancer response to therapy. Nat Med 14: 343-349.
32. Network CGAR, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068.
33. Morris EJ, Dreixler JC, Cheng KY, Wilson PM, Gin RM, et al. (1999) Optimization of single-cell gel electrophoresis (SCGE) for quantitative analysis of neuronal DNA damage. Biotechniques 26: 282-283, 286-289.
34. Wang J, An H, Mayo MW, Baldwin AS, Yarbrough WG, (2007) LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB. Cancer Cell 12: 239-251.
35. Vazquez A, Bond EE, Levine AJ, Bond GL, (2008) The genetics of the p53 pathway, apoptosis and cancer therapy. Nat Rev Drug Discov 7: 979-987.
36. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, et al. (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 276: 36734-36741.
37. Banerjee M, Huang C, Marquez J, Mohanty S, (2008) Probing the structure and function of human glutaminase-interacting protein: a possible target for drug design. Biochemistry 47: 9208-9219.
38. Alewine C, Kim BY, Hegde V, Welling PA, (2007) Lin-7 targets the Kir 2.3 channel on the basolateral membrane via a L27 domain interaction with CASK. Am J Physiol Cell Physiol 293: C1733-1741.
39. Zhang J, Yan X, Shi C, Yang X, Guo Y, et al. (2008) Structural basis of beta-catenin recognition by Tax-interacting protein-1. J Mol Biol 384: 255-263.
40. Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, et al. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303: 844-848.